Buyback Update: Aurobindo Pharma Buyback – Record Date Announced

As per the recent notification issued by the BSE, Aurobindo Pharma has announced a buyback of equity shares via the tender offer route and has fixed 17 April 2026 as the Record Date to determine shareholder eligibility.

What this means for you

If you are holding shares of Aurobindo Pharma Ltd. as on the record date, you will be eligible to participate in the buyback offer. This provides an opportunity to tender your shares to the company, subject to the final buyback terms, including price and entitlement ratio, which will be announced separately.

Key highlights:

• Company: Aurobindo Pharma Ltd.
• Corporate Action: Buyback (Tender Offer)
• Buyback Size: ₹800 crores
• Shares to be Bought Back: Up to 0.54 crore equity shares
• Buyback Price: ₹1,475 per share
• Face Value: ₹10 per share
• Record Date: 17 April 2026
• Ex-Entitlement Date: 17 April 2026
• BSE Code: 524804
   

Our view

Buybacks are generally considered a positive signal, reflecting management’s confidence in the company’s fundamentals. They may also offer investors an opportunity to realize value, depending on the buyback price and acceptance ratio.

Next steps

We recommend that you:

• Review your holdings in Aurobindo Pharma ahead of the record date
• Stay tuned for further details on the buyback price and process
• Reach out to your relationship manager for assistance in evaluating participation

Please feel free to connect with us for any clarification or guidance regarding this opportunity.